Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jul;66(7):974-6.
doi: 10.1136/ard.2006.067447. Epub 2007 Mar 28.

Why are Dutch rheumatologists reluctant to use the COBRA treatment strategy in early rheumatoid arthritis?

Affiliations

Why are Dutch rheumatologists reluctant to use the COBRA treatment strategy in early rheumatoid arthritis?

Lilian H D van Tuyl et al. Ann Rheum Dis. 2007 Jul.

Abstract

Background: The Combinatietherapie Bij Reumatoide Artritis (COBRA) trial has proved that combination therapy with prednisolone, methotrexate and sulphasalazine is superior to sulphasalazine monotherapy in suppressing disease activity and radiological progression of early rheumatoid arthritis (RA). In addition, 5 years of follow-up proved that COBRA therapy results in sustained reduction of the rate of radiological progression. Despite this evidence, Dutch rheumatologists seem reluctant to prescribe COBRA therapy.

Objective: To explore the reasons for the reluctance in Dutch rheumatologists to prescribe COBRA therapy.

Methods: A short structured questionnaire based on social-psychological theories of behaviour was sent to all Dutch rheumatologists (n = 230).

Results: The response rate was 50%. COBRA therapy was perceived as both effective and safe, but complex to administer. Furthermore, rheumatologists expressed their concern about the large number of pills that had to be taken, the side effects of high-dose prednisolone and the low dose of methotrexate. Although the average attitude towards the COBRA therapy was slightly positive (above the neutral point), the majority of responding rheumatologists had a negative intention (below the neutral point) to prescribe COBRA therapy in the near future.

Conclusion: The reluctance of Dutch rheumatologists to prescribe effective COBRA therapy may be due to perceptions of complexity of the treatment schedule and negative patient-related consequences of the therapy.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Boers M, Verhoeven A C, Markusse H M, Van De Laar M A, Westhovens R, Van Denderen J C.et al Randomised comparison of combined step‐down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet. 1997 2 350309–318. - PubMed
    1. Landewe R B, Boers M, Verhoeven A C, Westhovens R, Van De Laar M A, Markusse H M.et al Cobra combination therapy in patients with early rheumatoid arthritis: long‐term structural benefits of a brief intervention. Arthritis Rheum 200246347–356. - PubMed
    1. Korthals‐De Bos I B C, Van Tulder M W, Boers M, Verhoeven A C, Ader H J, Bibo J C.et al Indirect and total cost of early rheumatoid arthritis: a randomised comparison of combined step‐down prednisolone, methotrexate, and sulphasalazine alone. J Rheumatol 2004311709–1716. - PubMed
    1. Verhoeven A C, Bibo J C, Boers M, Engel G L, Van Der Linden S. Cost‐effectiveness and cost‐utility of combination therapy in early rheumatoid arthritis: randomized comparison of combined step‐down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone. Br J Rheumatol 1998371102–1109. - PubMed
    1. Goekoop‐Ruiterman Y P M, De Vries‐Bouwstra J K, Allaart C F, Van Zeben D, Kerstens P J S M, Hazes J M W.et al Clinical and radiological outcomes of four different treatment strategies in patients with early rheumatoid arthritis (Best): a randomised controlled study. Arthritis Rheum 2005523381–3390. - PubMed

Publication types

MeSH terms